Are Nonnutritive Sweeteners Obesogenic? Associations between Diet, Faecal Microbiota, and Short-Chain Fatty Acids in Morbidly Obese Subjects

Journal of Obesity

Volumn 2019, Issue , 2019, Pages

  Farup, Per G ^a,b   Lydersen, Stian ^b   Valeur, Jørgen ^c  

^a INNLANDET HOSPITAL TRUST   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c LOVISENBERG DIAKONALE HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; INSULIN; METFORMIN; NONNUTRITIVE SWEETENER; SHORT CHAIN FATTY ACID; STARCH; VALERIC ACID; SWEETENING AGENT; VOLATILE FATTY ACID;

ADULT; AGE; AGED; ANTIOBESITY ACTIVITY; ARTICLE; BEVERAGE; BODY MASS; BODY WEIGHT LOSS; CROSS-SECTIONAL STUDY; DIET; DYSBIOSIS; DYSLIPIDEMIA; FECES MICROFLORA; FEMALE; FLAME IONIZATION DETECTION; FOOD FREQUENCY QUESTIONNAIRE; GAS CHROMATOGRAPHY; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; NUTRITIONAL ASSESSMENT; SEX DIFFERENCE; DRUG EFFECT; FECES; INTESTINE FLORA; METABOLISM; MICROBIOLOGY; MIDDLE AGED; YOUNG ADULT;

ADULT; BUTYRIC ACID; CROSS-SECTIONAL STUDIES; DIET; FATTY ACIDS, VOLATILE; FECES; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; MALE; MIDDLE AGED; NON-NUTRITIVE SWEETENERS; OBESITY, MORBID; SWEETENING AGENTS; YOUNG ADULT;

EID: 85073598780     PISSN: 20900708     EISSN: 20900716     Source Type: Journal    
DOI: 10.1155/2019/4608315     Document Type: Article

References (50)

1. WHO, Fact Sheet N 311, Obesity and Overweight, WHO, Geneva, Switzerland, 2019, http://www.who.int/mediacentre/ factsheets/fs311/en/.
2. M. Abdelaal, C. W. le Roux, and N. G. Docherty, "Morbidity and mortality associated with obesity," Annals of Translational Medicine, vol. 5, no. 7, p. 161, 2017.
3. D. P. Guh, W. Zhang, N. Bansback, Z. Amarsi, C. L. Birmingham, and A. H. Anis, "The incidence of comorbidities related to obesity and overweight: a systematic review and meta-analysis," BMC Public Health, vol. 9, no. 1, p. 88, 2009.
4. WHO, Controlling the Global Obesity Epidemic, WHO, Geneva, Switzerland, 2019, http://www.who.int/nutrition/topics/ obesity/en/.
5. L. A. David, C. F. Maurice, R. N. Carmody et al., "Diet rapidly and reproducibly alters the human gut microbiome," Nature, vol. 505, no. 7484, pp. 559-563, 2014.
6. K. E. Bouter, D. H. van Raalte, A. K. Groen, and M. Nieuwdorp, "Role of the gut microbiome in the pathogenesis of obesity and obesity-related metabolic dysfunction," Gastroenterology, vol. 152, no. 7, pp. 1671-1678, 2017.
7. F. Del Chierico, F. Abbatini, A. Russo et al., "Gut microbiota markers in obese adolescent and adult patients: age-dependent differential patterns," Frontiers in Microbiology, vol. 9, p. 1210, 2018.
8. O. Castaner, A. Goday, Y.-M. Park et al., "The gut microbiome profile in obesity: a systematic review," International Journal of Endocrinology, vol. 2018, Article ID 4095789, 9 pages, 2018.
9. R. Gao, C. Zhu, H. Li et al., "Dysbiosis signatures of gut microbiota along the sequence from healthy, young patients to those with overweight and obesity," Obesity, vol. 26, no. 2, pp. 351-361, 2018.
10. T. Arora, R. Sharma, and G. Frost, "Propionate. Anti-obesity and satiety enhancing factor?," Appetite, vol. 56, no. 2, pp. 511-515, 2011.
11. C. K. Chakraborti, "New-found link between microbiota and obesity," World Journal of Gastrointestinal Pathophysiology, vol. 6, no. 4, pp. 110-119, 2015.
12. Z. Li, C.-X. Yi, S. Katiraei et al., "Butyrate reduces appetite and activates brown adipose tissue via the gut-brain neural circuit," Gut, vol. 67, no. 7, pp. 1269-1279, 2018.
13. S. A. H. Al-Lahham, M. P. Peppelenbosch, H. Roelofsen, R. J. Vonk, and K. Venema, "Biological effects of propionic acid in humans; metabolism, potential applications and underlying mechanisms," Biochimica et Biophysica Acta (BBA)- Molecular and Cell Biology of Lipids, vol. 1801, no. 11, pp. 1175-1183, 2010.
14. A. Andoh, A. Nishida, K. Takahashi et al., "Comparison of the gut microbial community between obese and lean peoples using 16S gene sequencing in a Japanese population," Journal of Clinical Biochemistry and Nutrition, vol. 59, no. 1, pp. 65-70, 2016.
15. A. Koliada, G. Syzenko, V. Moseiko et al., "Association between body mass index and Firmicutes/Bacteroidetes ratio in an adult Ukrainian population," BMC Microbiology, vol. 17, no. 1, p. 120, 2017.
16. M. Rajilic-Stojanovic and W. M. de Vos, "The first 1000 cultured species of the human gastrointestinal microbiota," FEMS Microbiology Reviews, vol. 38, pp. 996-1047, 2014.
17. D. S. H. Bell, "Changes seen in gut bacteria content and distribution with obesity: causation or association?," Postgraduate Medicine, vol. 127, no. 8, pp. 863-868, 2015.
18. G. D. Wu, J. Chen, C. Hoffmann et al., "Linking long-term dietary patterns with gut microbial enterotypes," Science, vol. 334, no. 6052, pp. 105-108, 2011.
19. K. P. Scott, S. H. Duncan, and H. J. Flint, "Dietary fibre and the gut microbiota," Nutrition Bulletin, vol. 33, no. 3, pp. 201-211, 2008.
20. S. A. Montandon and F. R. Jornayvaz, "Effects of antidiabetic drugs on gut microbiota composition," Genes, vol. 8, 2017.
21. H. Wu, E. Esteve, V. Tremaroli et al., "Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug," Nature Medicine, vol. 23, no. 7, pp. 850-858, 2017.
22. J. Suez, T. Korem, D. Zeevi et al., "Artificial sweeteners induce glucose intolerance by altering the gut microbiota," Nature, vol. 514, no. 7521, pp. 181-186, 2014.
23. J. Suez, T. Korem, G. Zilberman-Schapira, E. Segal, and E. Elinav, "Non-caloric artificial sweeteners and the microbiome: findings and challenges," Gut Microbes, vol. 6, no. 2, pp. 149-155, 2015.
24. T. Feehley and C. R. Nagler, "The weighty costs of non-caloric sweeteners," Nature, vol. 514, no. 7521, pp. 176-177, 2014.
25. P. G. Farup, M. Aasbrenn, and J. Valeur, "Separating "good" from "bad" faecal dysbiosis-evidence from two cross-sectional studies," BMC Obesity, vol. 5, no. 1, p. 30, 2018.
26. F. Shanahan, D. van Sinderen, P. W. O'Toole, and C. Stanton, "Feeding the microbiota: transducer of nutrient signals for the host," Gut, vol. 66, no. 9, pp. 1709-1717, 2017.
27. R. Winther, M. Aasbrenn, and P. G. Farup, "Intake of nonnutritive sweeteners is associated with an unhealthy lifestyle: a cross-sectional study in subjects with morbid obesity," BMC Obesity, vol. 4, no. 1, p. 41, 2017.
28. P. Farup and J. Valeur, "Faecal microbial markers and psychobiological disorders in subjects with morbid obesity. A cross-sectional study," Behavioral Sciences, vol. 8, no. 10, p. 89, 2018.
29. The Norwegian food composition table, 2019, http://www. matvaretabellen.no/?languageen.
30. C. Caśen, H. C. Vebø, M. Sekelja et al., "Deviations in human gut microbiota: a novel diagnostic test for determining dysbiosis in patients with IBS or IBD," Alimentary Pharmacology "?erapeutics, vol. 42, no. 1, pp. 71-83, 2015.
31. Genetic Analysis AS, "GAMap TM dysbiosis test," 2019, http://www.genetic-analysis.com/patent.
32. J. B. Zijlstra, J. Beukema, B. G. Wolthers, B. M. Byrne, A. Groen, and J. D. Ankert, "Pretreatment methods prior to gaschromatographic analysis of volatile fatty acids from faecal samples," Clinica Chimica Acta, vol. 78, no. 2, pp. 243-250, 1977.
33. T. Høverstad, A. Bjørneklett, T. Midtvedt, O. Fausa, and T. Bøhmer, "Short-chain fatty acids in the proximal gastrointestinal tract of healthy subjects," Scandinavian Journal of Gastroenterology, vol. 19, pp. 1053-1058, 1984.
34. B. Tjellstrom, L. Hogberg, L. Stenhammar et al., "Effect of exclusive enteral nutrition on gut microflora function in children with Crohn's disease," Scandinavian Journal of Gastroenterology, vol. 47, no. 12, pp. 1454-1459, 2012.
35. A. F. Hayes and N. J. Rockwood, "Regression-based statistical mediation and moderation analysis in clinical research: observations, recommendations, and implementation," Behaviour Research and ?erapy, vol. 98, pp. 39-57, 2017.
36. A. F. Hayes, Introduction to Mediation, Moderation, and Conditional Process Analysis: A Regression-Based Approach, Guilford Press, New York, NY, USA, Second edition, 2018.
37. T. Uebanso, A. Ohnishi, R. Kitayama et al., "Effects of lowdose non-caloric sweetener consumption on gut microbiota in mice," Nutrients, vol. 9, no. 6, p. 560, 2017.
38. R. B. Canani, M. D. Costanzo, L. Leone, M. Pedata, R. Meli, and A. Calignano, "Potential beneficial effects of butyrate in intestinal and extraintestinal diseases," World Journal of Gastroenterology, vol. 17, no. 12, pp. 1519-1528, 2011.
39. J. Whitt, V. Woo, P. Lee et al., "Disruption of epithelial HDAC3 in intestine prevents diet-induced obesity in mice," Gastroenterology, vol. 155, no. 2, pp. 501-513, 2018.
40. K. S. Fluitman, M. Wijdeveld, M. Nieuwdorp, and R. G. Ijzerman, "Potential of butyrate to influence food intake in mice and men," Gut, vol. 67, no. 7, pp. 1203-1204, 2018.
41. F. De Vadder, P. Kovatcheva-Datchary, D. Goncalves et al., "Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits," Cell, vol. 156, pp. 84-96, 2014.
42. C. Cŕeźe, L. Candal, J. Cros et al., "The impact of caloric and non-caloric sweeteners on food intake and brain responses to food: a randomized crossover controlled trial in healthy humans," Nutrients, vol. 10, no. 5, p. 615, 2018.
43. I. Toews, S. Lohner, D. Kullenberg de Gaudry, H. Sommer, and J. J. Meerpohl, "Association between intake of non-sugar sweeteners and health outcomes: systematic review and metaanalyses of randomised and non-randomised controlled trials and observational studies," BMJ, vol. 364, p. k4718, 2019.
44. J. Feng, H. Tang, M. Li et al., "The abundance of fecal Faecalibacterium prausnitzii in relation to obesity and gender in Chinese adults," Archives of Microbiology, vol. 196, no. 1, pp. 73-77, 2014.
45. C. V. Ferreira-Halder, A. V. d. S. Faria, and S. S. Andrade, "Action and function of Faecalibacterium prausnitzii in health and disease," Best Practice "Research Clinical Gastroenterology, vol. 31, no. 6, pp. 643-648, 2017.
46. H. J. Flint, K. P. Scott, S. H. Duncan, P. Louis, and E. Forano, "Microbial degradation of complex carbohydrates in the gut," Gut Microbes, vol. 3, no. 4, pp. 289-306, 2012.
47. P. Louis and H. J. Flint, "Formation of propionate and butyrate by the human colonic microbiota," Environmental Microbiology, vol. 19, no. 1, pp. 29-41, 2017.
48. K. Luo, X. Wang, and G. Zhang, "The anti-obesity effect of starch in a whole grain-like structural form," Food "Function, vol. 9, no. 7, pp. 3755-3763, 2018.
49. K. Forslund, F. Hildebrand, T. Nielsen et al., "Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota," Nature, vol. 528, no. 7581, pp. 262-266, 2015.
50. K. J. Rothman, "Six persistent research misconceptions," Journal of General Internal Medicine, vol. 29, no. 7, pp. 1060-1064, 2014.